Health Insurance Innovations Receives New Coverage from Analysts at Dougherty & Co (HIIQ)
Dougherty & Co began coverage on shares of Health Insurance Innovations (NASDAQ:HIIQ) in a research note issued on Friday, TheFlyOnTheWall.com reports. The firm set a “buy” rating on the stock.
Several other analysts have also recently commented on the stock. Analysts at Zacks upgraded shares of Health Insurance Innovations from an “underperform” rating to a “neutral” rating in a research note on Tuesday, May 20th. They now have a $10.80 price target on the stock. Separately, analysts at Raymond James reiterated a “strong-buy” rating on shares of Health Insurance Innovations in a research note on Monday, April 14th. They now have a $15.00 price target on the stock.
Health Insurance Innovations (NASDAQ:HIIQ) opened at 10.41 on Friday. Health Insurance Innovations has a 52-week low of $8.39 and a 52-week high of $14.08. The stock’s 50-day moving average is $10.03 and its 200-day moving average is $10.77. The company has a market cap of $53.8 million and a price-to-earnings ratio of 187.74.
Health Insurance Innovations (NASDAQ:HIIQ) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.08 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.08. Analysts expect that Health Insurance Innovations will post $0.39 EPS for the current fiscal year.
In other Health Insurance Innovations news, CEO Michael W. Kosloske unloaded 5,943 shares of the stock on the open market in a transaction dated Thursday, June 5th. The stock was sold at an average price of $10.21, for a total value of $60,678.03. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Health Insurance Innovations, Inc is a developer and administrator of Web-based individual health insurance plans and ancillary products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.